Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Livestream 2021
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • CCC Excellence Lecture
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Leukemia. 2015 Apr 14. pii: leu201594. doi: 10.1038/leu.2015.94
    Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival.
    Creutzig U1,  Dworzak MN2,  Zimmermann M3,  Bourquin JP4,  Gruhn B5,  Fleischhack G6,  Graf N7,  Klingebiel T8,  Kremens B9,  Lehrnbecher T10,  von Neuhoff C11,  Stackelberg AV12,  Starý J13,  Reinhardt D14
    Author information
    1Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany.
    2St Anna Children's Hospital and Children's Cancer Research Institute, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
    3Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany.
    4Pediatric Hematology/Oncology, University of Zurich, Zurich, Switzerland.
    5Department of Pediatrics, Jena University Hospital, Jena, Germany.
    6Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany.
    7Department of Pediatric Oncology and Hematology, Medical School, Saarland University, Homburg, Germany.
    8Pediatric Hematology, Oncology and Hemostaseology, University Children's Hospital of Frankfurt/Main, Goethe-University Frankfurt/Main, Frankfurt/Main, Germany.
    9Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany.
    10Pediatric Hematology, Oncology and Hemostaseology, University Children's Hospital of Frankfurt/Main, Goethe-University Frankfurt/Main, Frankfurt/Main, Germany.
    11Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany.
    12Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany.
    13Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Czech Pediatric Hematology Working Group (CPH), Prague, Czech Republic.
    141] Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany [2] Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany.

    Publikations ID: 25869725
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    21sextury.org fake hub hd sexy hub eroticax.org
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt